HomeATNM • NYSEAMERICAN
Actinium Pharmaceuticals Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 90.00K | — |
Operating expense | 5.78M | -54.11% |
Net income | -5.13M | 55.64% |
Net profit margin | -5.70K | — |
Earnings per share | -0.16 | 56.76% |
EBITDA | -5.49M | 55.75% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 53.39M | -32.12% |
Total assets | 56.15M | -31.62% |
Total liabilities | 42.37M | -3.51% |
Total equity | 13.78M | — |
Shares outstanding | 31.20M | — |
Price to book | 3.25 | — |
Return on assets | -23.88% | — |
Return on capital | -80.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.13M | 55.64% |
Cash from operations | -6.33M | 47.18% |
Cash from investing | — | — |
Cash from financing | -209.00K | -104.54% |
Net change in cash | -6.53M | 11.38% |
Free cash flow | -4.72M | 50.28% |
Previous close
$1.43
Day range
$1.38 - $1.44
Year range
$1.03 - $2.41
Market cap
43.05M USD
Avg Volume
296.84K
P/E ratio
-
Dividend yield
-
About
CEO
Founded
2000
Website
Employees
27
